Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, BFA

Midwest Institute for Nonsurgical Therapy (MINT) Now Offers Innovative Treatment for Enlarged Prostate


ST. LOUIS, April 18, 2024 /PRNewswire/ -- The Midwest Institute for Nonsurgical Therapy (MINT), a leading provider of minimally invasive medical procedures, is proud to announce the introduction of Prostate Artery Embolization (PAE) for the treatment of Benign Prostatic Hyperplasia (BPH), commonly known as enlarged prostate. This cutting-edge procedure is now available at all MINT locations in St. Louis, MO, Swansea, IL, and Evergreen Park (Chicago), IL.

Under the leadership of Dr. Olaguoke Akinwande, Medical Director and owner of MINT, the practice is pioneering this advanced treatment option, which is now covered by both private insurance and Medicare. "We are thrilled to offer Prostate Artery Embolization, a nonsurgical treatment that significantly improves the quality of life for patients suffering from BPH," said Dr. Akinwande. "Our commitment is to provide our patients with the latest and most effective treatments available, and PAE represents a major advancement in how we manage BPH."

Prostate Artery Embolization is a minimally invasive procedure performed by an interventional radiologist. It involves placing a catheter into the artery supplying the prostate to deliver microscopic particles that block blood flow, causing the prostate to shrink and alleviate symptoms. The benefits of PAE include shorter recovery times, less risk than traditional surgery, and significant relief of symptoms. PAE does not have the sexual side effects commonly associated with with TURP.

MINT is among the few practices in the Midwest to offer this innovative service, positioning itself as a leader in nonsurgical therapies. With the inclusion of PAE in their services, MINT reinforces its dedication to offering state-of-the-art treatments that enhance patient outcomes and satisfaction.

Patients seeking more information about Prostate Artery Embolization or to schedule a consultation can visit www.mintstl.com or contact MINT at 314 255 2204.

About Midwest Institute for Nonsurgical Therapy (MINT)

The Midwest Institute for Nonsurgical Therapy is committed to providing the highest standard of care in minimally invasive treatments. Led by Dr. Olaguoke Akinwande, MINT offers a range of services aimed at treating vascular and non-vascular conditions without surgery. With locations in Missouri and Illinois, MINT utilizes the latest technologies and treatment methods to ensure the best outcomes for their patients.

Contact:

Kyara Jackson
Office Manager
Midwest Institute for Nonsurgical Therapy
314 255 2204
[email protected]
www.mintstl.com

SOURCE Midwest Institute for Nonsurgical Therapy


These press releases may also interest you

at 17:49
The ALS Association today celebrated the beginning of ALS Awareness Month and the 10th Anniversary of the Ice Bucket Challenge, which inspired the world to join the fight against ALS in the summer of 2014. Throughout May and the summer, the ALS...

at 17:31
White Glove Placement, a leading provider of staffing solutions for healthcare facilities, is proud to announce its "Scoops of Gratitude" Free Ice Cream Truck to celebrate Nurses Week and show appreciation for the dedication and hard work of nurses...

at 17:31
DelveInsight's Opioid Withdrawal...

at 17:30
Two El Camino Health hospitals in the South Bay have earned the highest ranking for patient safety from The Leapfrog Group, a national, not-for-profit, independent evaluator that measures excellence in patient care. This national distinction marks...

at 17:25
Myomo, Inc. ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the...

at 17:23
EVP Capital Inc. ("EVP Capital"), a capital pool company ("CPC") listed on the TSX Venture Exchange Inc. (the "Exchange"), is pleased to announce that it has entered into a non-binding letter of intent dated May 1, 2024 (the "LOI") with Sharp Edge...



News published on and distributed by: